Helen Wheeler
Impact in
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Genetics 81
- Glioma Diagnosis and Treatment 77
-
- Brain Metastases and Treatment 36
- Co-authors
- Viive M. HowellJonathon ParkinsonMustafa KhasrawNicole ParkerMichael BackNick PavlakisGillian M. ShenfieldNicholas Little
- Journals
- Journal of Clinical Oncology (14 papers)Journal of Neuro-Oncology (9 papers)Neuro-Oncology (9 papers)Cochrane Database of Systematic Reviews (4 papers)Cancers (3 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Helen Wheeler
107 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 123
- Genetics 1.4k
- Cancer Research 574
- Oncology 671
- Pulmonary and Respiratory Medicine 590
- Neurology 267
Countries citing papers authored by Helen Wheeler
This map shows the geographic impact of Helen Wheeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Wheeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Wheeler more than expected).
Fields of papers citing papers by Helen Wheeler
This network shows the impact of papers produced by Helen Wheeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Wheeler. The network helps show where Helen Wheeler may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Wheeler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 12 | |
| 5 | 2021 | 28 | |
| 6 | 2020 | 19 | |
| 7 | 2020 | 4 | |
| 8 | A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY | 2019 | 1 |
| 9 | ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer | 2018 | 1 |
| 10 | 2018 | 41 | |
| 11 | 2018 | 28 | |
| 12 | 2017 | 10 | |
| 13 | 2017 | 19 | |
| 14 | 2016 | 50 | |
| 15 | 2015 | 51 | |
| 16 | 2015 | 113 | |
| 17 | 2012 | 46 | |
| 18 | 2008 | 22 | |
| 19 | 1992 | 52 | |
| 20 | 1990 | 3 |
About Helen Wheeler
Helen Wheeler is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 110 papers that have together received 2.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (77 papers), Brain Metastases and Treatment (36 papers), Meningioma and schwannoma management (16 papers), Radiomics and Machine Learning in Medical Imaging (14 papers), Cancer, Hypoxia, and Metabolism (10 papers), Cancer Genomics and Diagnostics (7 papers), Medical Imaging Techniques and Applications (7 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Genetics (1.4k citations), Cancer Research (574 citations), Oncology (671 citations), Pulmonary and Respiratory Medicine (590 citations) and Neurology (267 citations). Helen Wheeler has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Viive M. Howell, Jonathon Parkinson, Mustafa Khasraw, Nicole Parker, Michael Back, Nick Pavlakis, Gillian M. Shenfield, Nicholas Little, Michael T. Biggs and Raymond Cook. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology, Neuro-Oncology, Cochrane Database of Systematic Reviews and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.